Never Was doesn't know what he's talking about. And never did.
All of this is Romper Room Temper Tantrums from amateurs. The truth is far simpler and nothing complex about it. This is how simple it is: Stocks follow fundamentals long term. Period. Doesn't matter what you do or say, nothing can change that fact. That's why I love the stock market. Because no matter what, truth always comes out of the shake. Nobody needs to kiss your little tuches or even give you the time of day. All that matters is truth.
The truth is this: HLIX was priced too high. All of you that took it on the chin bought high. Nothing complex about that. I bought some high too because there is no guarantee that the cannabis industry would have come down to proper valuations. There was a flight from the entire industry to quality. Plus, Covid and other economy jitters. Margin calls, entrepreneurs bringing their chips in, etc.
If the fundamentals are there, the demand will be there. The only issue is toxic funding whereby someone can convert at a discount. In that case, the lower the price, the more the conversion. HLIX benefitted from high prices in that they were able to acquire some good companies. Thank you very much. Now those valuations are right where they should be as I explained before. .11 was margin of safety, .20's is a good value in my opinion, and .50 would kinda high but you never know the cannabis industry as a whole will be overpriced again. And, eventually if HLIX stays the course, it will be worth .50 for a value investor. There are all types of investors. The squeaky wheels here are -- well, we don't need to go there.
It's just that simple. It's not rocket science. You are overthinking it. Looking for conspiracy theories. Acting rude. All signs of weakness. The loudest one in the room is the weakest one in the room. Of course ,there are some exceptions to every rule (looking to myself here). :)
HLIX has been on the rise since its inception. Improving its fundamentals yearly. The stock has always been far above its valuation. The the stock finally came down to meet a HLIX on the rise. Think of it as a rising HLIX meets a falling ceiling. The stock is not the company.
The good thing for HLIX at these prices is that the physics change against the "toxic" math. The fundamentals are there to support these prices because HLIX is real. And the fundamentals look better than KERN to me. Heck, KERN is software yet we still have better margins. Because are margins at Biotrack alone are at 70% blowing KERN's away. Which corroborates all the testimony out there in regard to MJ's discounting. The truth is going to come out of the shake.
KERN's price is manipulation as I see it. Lots of restricted shares, high potential for their recent round to become toxic, and like all SPAC's, it's just a matter of time before HLIX and KERN meet in market cap valuations. If the fundamentals of both stay the course, that is. You can't deny truth. Long term, the market is a weighnig machine. Short term, it's a voting machine.
